These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24648463)

  • 1. Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence.
    Hildebrandt E; Dunn JR; Perumbakkam S; Niikura M; Cheng HH
    J Virol; 2014 Jun; 88(11):6232-42. PubMed ID: 24648463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mut UL5-I682R Marek's Disease Virus with a Single Nucleotide Mutation Within the Helicase-Primase Subunit Gene not only Reduces Virulence but also Provides Partial Vaccinal Protection Against Marek's Disease.
    Hildebrandt E; Dunn JR; Cheng HH
    Avian Dis; 2015 Mar; 59(1):94-7. PubMed ID: 26292541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing in vivo stability and potential interactions of a UL5 helicase-primase mutation previously shown to reduce virulence and in vivo replication of Marek's disease virus.
    Hildebrandt E; Dunn JR; Cheng HH
    Virus Res; 2015 May; 203():1-3. PubMed ID: 25828576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection.
    Hildebrandt E; Dunn JR; Cheng HH
    Avian Pathol; 2015; 44(4):254-8. PubMed ID: 25968878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.
    Spatz SJ; Rue C; Schumacher D; Osterrieder N
    Virus Genes; 2008 Aug; 37(1):69-80. PubMed ID: 18516669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL; Kreager KS
    Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
    Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Marek's disease virus genes associated with virulence of US strains.
    Dunn JR; Black Pyrkosz A; Steep A; Cheng HH
    J Gen Virol; 2019 Jul; 100(7):1132-1139. PubMed ID: 31184569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens.
    Heine HG; Foord AJ; Young PL; Hooper PT; Lehrbach PR; Boyle DB
    Virus Res; 1997 Jul; 50(1):23-33. PubMed ID: 9255932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural co-infection with two virulent wild strains of Marek's disease virus in a commercial layer flock.
    Yu Z; Zhang Y; Lan X; Wang Y; Zhang F; Gao Y; Li K; Gao L; Pan Q; Qi X; Cui H; Zhou L; Sun G; Wang X; Liu C
    Vet Microbiol; 2020 Jan; 240():108501. PubMed ID: 31902513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization.
    Eschke K; Trimpert J; Osterrieder N; Kunec D
    PLoS Pathog; 2018 Jan; 14(1):e1006857. PubMed ID: 29377958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and Identification of Marek's Disease Virus BAC Clones as Standardized Reagents for Research.
    Dunn JR; Reddy SM; Niikura M; Nair V; Fulton JE; Cheng HH
    Avian Dis; 2017 Mar; 61(1):107-114. PubMed ID: 28301231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
    Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus.
    Spatz SJ; Zhao Y; Petherbridge L; Smith LP; Baigent SJ; Nair V
    Virus Genes; 2007 Dec; 35(3):753-66. PubMed ID: 17721813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential attenuation of Marek's disease virus-induced tumours and late-Marek's disease virus-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Reddy SM; Gimeno IM
    J Gen Virol; 2018 Jul; 99(7):927-936. PubMed ID: 29767614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and phylogenetic analysis of oncogenes from virulent serotype-1 Marek's disease virus in India.
    Prathibha Y; Sreedevi B; Kumar NV; Srilatha CH
    Acta Virol; 2018; 62(3):277-286. PubMed ID: 30160143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.